Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention

American Journal of Cardiology

Volumn 112, Issue 4, 2013, Pages 493-498

  Kiviniemi, Tuomas ^a   Karjalainen, Pasi ^b   Rubboli, Andrea ^c   Schlitt, Axel ^d   Tuomainen, Petri ^e   Niemelä, Matti ^f   Laine, Mika ^g   Biancari, Fausto ^f   Lip, Gregory Y H ^h   Airaksinen, K E Juhani ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b SATAKUNTA CENTRAL HOSPITAL   (Finland)

^c MAGGIORE HOSPITAL   (Italy)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f OULU UNIVERSITY HOSPITAL   (Finland)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; DALTEPARIN; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HIRULOG; PRASUGREL;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY EMBOLISM; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT THROMBOSIS; THROMBOCYTOPENIA; TRANSIENT ISCHEMIC ATTACK;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CORONARY ANGIOGRAPHY; DATA INTERPRETATION, STATISTICAL; FEMALE; HEMORRHAGE; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET COUNT; PROSPECTIVE STUDIES; STENTS; THROMBOCYTOPENIA;

EID: 84881191019     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.04.007     Document Type: Article

References (13)

1. G.Y.H. Lip, K. Huber, F. Andreotti, H. Arnesen, J.K. Airaksinen, T. Cuisset, P. Kirchhof, and F. Marín Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary - a consensus document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31 2010 1311 1318
2. J.W. Eikelboom, S.S. Anand, S.R. Mehta, J.I. Weitz, C. Yi, and S. Yusuf Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: organization to assess strategies for ischemic syndromes (OASIS-2) study Circulation 103 2001 643 650
3. E. Nikolsky, H.M. Sadeghi, M.B. Effron, R. Mehran, A.J. Lansky, Y. Na, D.A. Cox, E. Garcia, J.E. Tcheng, J.J. Griffin, T.D. Stuckey, M. Turco, J.D. Carroll, C.L. Grines, and G.W. Stone Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction Am J Cardiol 96 2005 474 481
4. R.W. Yeh, S.D. Wiviott, R.P. Giugliano, D.A. Morrow, A. Shui, J. Qin, B. Scirica, J.E. Bradner, I. Jang, C.M. Gibson, and E.M. Antman Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes Am J Cardiol 100 2007 1734 1738
5. C.B. Overgaard, J. Ivanov, P.H. Seidelin, M. Todorov, K. Mackie, and V. Dzavik Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention Am Heart J 156 2008 120 124
6. G.B. Oliveira, E.M. Crespo, R.C. Becker, E.F. Honeycutt, C.S. Abrams, K.J. Anstrom, P.B. Berger, L.D. Davidson-Ray, E.L. Eisenstein, N.S. Kleiman, D.J. Moliterno, S. Moll, L. Rice, J.E. Rodgers, S.R. Steinhubl, V.F. Tapson, E.M. Ohman, and C.B. Granger Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy Arch Intern Med 168 2008 94 102
7. T.Y. Wang, F. Ou, M.T. Roe, R.A. Harrington, E.M. Ohman, W.B. Gibler, and E.D. Peterson Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice Circulation 119 2009 2454 2462
8. A. De Labriolle, L. Bonello, G. Lemesle, P. Roy, D.H. Steinberg, Z. Xue, W.O. Suddath, L.F. Satler, K.M. Kent, A.D. Pichard, J. Lindsay, and R. Waksman Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors Eur Heart J 31 2010 1079 1087
9. H. Lahtela, A. Rubboli, A. Schlitt, P.P. Karjalainen, M. Niemelä, S. Vikman, M. Puurunen, M. Weber, J. Valencia, F. Biancari, G.Y.H. Lip, K.E.J. Airaksinen AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting), study group Heparin bridging vs. uninterrupted oral anticoagulation in patients with atrial fibrillation undergoing coronary artery stenting; - results from the AFCAS registry Circ J 76 2012 1363 1368
10. T. Kiviniemi, P. Karjalainen, M. Pietilä, A. Ylitalo, M. Niemelä, S. Vikman, M. Puurunen, F. Biancari, and K.E.J. Airaksinen Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention Am J Cardiol 110 2012 30 35
11. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G. van Es, P. Gabriel Steg, M. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials Circulation 115 2007 2344 2351
12. R. Mehran, S.V. Rao, D.L. Bhatt, C.M. Gibson, A. Caixeta, J. Eikelboom, S. Kaul, S.D. Wiviott, V. Menon, E. Nikolsky, V. Serebruany, M. Valgimigli, P. Vranckx, D. Taggart, J.F. Sabik, D.E. Cutlip, M.W. Krucoff, E.M. Ohman, P.G. Steg, and H. White Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium Circulation 123 2011 2736 2747
13. B. Lewis Thrombocytopenia and outcome in invasive cardiology J Invasive Cardiol 14 Suppl B 2002 38B 47B